1. A-VAX (2012) Applying quality by design to vaccines. CMC-vaccines working groupcmc-vaccines working group
2. Akers M (1984) Considerations in selecting antimicrobial preservatives for parenteral product development. Pharm Technol 8:36–44
3. Akers M, Defelippis M (2000) Peptides and proteins as parenteral solutions. In: Frokjaer S, Hovgarrd L (eds) Pharmaeutical formulation development of peptides and proteins. Taylor and Francis, Philadelphia, pp 145–177
4. Bontempo J (1997) Formulation development. In Bontempo JA (ed) Development of biopharmaceutical parental dosage forms. Marcel Dekker, New York, pp 109–142
5. Brandau DT, Jones LS, Wiethoff CM, Rexroad J, Middaugh CR (2003) Thermal stability of vaccines. J Pharm Sci 92:218–231